Search the Newsreel

Is Lifeward Ltd (LFWD) Positioned for Growth After Q2 Earnings?

Lifeward Q2 2026 Earnings Preview

* Lifeward (LFWD [https://seekingalpha.com/symbol/LFWD]) is scheduled to announce Q2 earnings results on Friday, August 14th, before market open. * The consensus EPS Estimate is -$1.28 [https://seekingalpha.com/symbol/LFWD/earnings/estimates] (-312.9% Y/Y) and the consensus Revenue Estimate is $6.53M (+14.2% Y/Y). * Over the last 2 years, LFWD …

Earnings To Watch: Lifeward Ltd (LFWD) Q2 2026 -- GF Value Sees 185% Upside

Lifeward Ltd (LFWD) Stock News Today

This article provides a stock news update for Lifeward Ltd (LFWD), noting its current stock price, market capitalization, and a message that more news is coming soon. It lists various financial and analytical tools available on the TradingKey platform for LFWD.

Lifeward Ltd (LFWD) Earnings Forecast: Future EPS & Revenue Growth Estimates

Lifeward Ltd (LFWD) has an earnings forecast score of 8.00, ranking 65th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $4.50, with a high of $10.00 and a low of $1.00. Based on ratings from two analysts, …

Lifeward Out With Q2 Numbers

Lifeward Ltd. (NASDAQ: LFWD), a biomedical innovation company, announced it will report its second-quarter 2026 financial results on Friday, August 14. The company has a portfolio of neurorehabilitation products and is expanding into diversified biomedical platforms, including its Protein Oral Delivery (POD™) platform for …

Lifeward to issue Q2 results before 9:30 a.m. Aug. 14; no call

Lifeward (Nasdaq: LFWD) announced it will report its second-quarter 2026 financial results on Friday, August 14, 2026. A press release and quarterly report will be available and filed with the SEC before 9:30 a.m. ET. The company also stated it will not hold a …

Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026

Lifeward Ltd. (Nasdaq: LFWD) announced it will report its second quarter 2026 financial results on Friday, August 14, 2026. A press release will be issued and a quarterly report filed with the SEC before 9:30 a.m. ET, though no conference call will be held. …

LFWD Q2'26 Earnings: revenue estimate is 6.53M USD

Lifeward Ltd. (LFWD) is expected to announce its Q2'26 earnings on August 12, with a revenue estimate of $6.53 million and an anticipated EPS of -$1.39. The article provides a detailed table comparing past reported and estimated revenues and EPS, including surprise percentages, for …

Lifeward Launches ReWalk 7 Pilot Program with Ottobock Care to Expand U.S. Patient Access

Lifeward Ltd. has partnered with Ottobock Care to launch a six-month pilot program aimed at increasing U.S. patient access to the ReWalk® 7 Personal Exoskeleton. The initiative will leverage Ottobock Care's extensive clinical expertise and patient care infrastructure across over 50 clinics to raise …

Enterprise value to revenue forward of Lifeward Ltd. – NASDAQ:LFWD

This article displays the "Enterprise value to revenue forward" for Lifeward Ltd. (NASDAQ: LFWD) on TradingView. It shows the period, value, and change percentages for this financial metric. The content primarily focuses on presenting this specific financial data point for the company.

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024

Lifeward (Nasdaq: LFWD) announced it will release its fourth quarter and fiscal year-end 2023 financial results before market open on Tuesday, February 27, 2024. The company will host a conference call and live webcast at 8:30 a.m. EST to discuss these results. Lifeward is …

LFWD|Lifeward Ltd|Price:6.960|Chg%:-0.153

This article provides a comprehensive stock analysis of Lifeward Ltd (LFWD) by TradingKey. It details the company's fundamentals, valuation, growth potential, and institutional ownership, noting a "Buy" rating from analysts with a target price of $20.00. Lifeward Ltd, formerly ReWalk Robotics Ltd, designs and …

LFWD|Lifeward Ltd|Price:7.050|Chg%:-0.105

Lifeward Ltd (LFWD) is a medical device company specializing in exoskeletons for people with mobility impairments. The company's stock is currently trading at $7.050, down 1.48%, with a high institutional ownership and healthy fundamentals, including an average revenue growth of 59.04% over the past …

Lifeward (LFWD) Q1 2026 Earnings Transcript

ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.

ReWalk Robotics Ltd. (LFWD) Stock Forecast & Price Prediction 2026–2030

ReWalk Robotics Stock Up 56%: Great Origin Story, Poor Financial Prospects

Rewalk Robotics (RWLK) Stock Price Rallied 42.3% as Retail Investors Pushed It Higher

ReWalk Robotics Raises $20M to Expand into China